According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market.
Download exclusive Sample of this report:
A number of cases related to renal failure are being reported every day across the world, thanks to the increasing prevalence of diabetes and various kidney diseases. Renal failure or kidney failure is a medical condition, in which kidneys fail to filter waste and excess water from the patient’s blood. In this case, the patient needs dialysis, which is the process of purifying the blood of the patient suffering from renal failure by removing extra fluids and waste products and by controlling the fluidic levels of the patient’s body.
The rising incidence of renal failure has fuelled the demand for dialysis products and services significantly in the global arena. According to the report, the rapid increase in the geriatric population has added considerably to the number of patients suffering from diabetes and chronic kidney diseases, leading to a large renal failure patient pool.
The implementation of favorable reimbursement policies by various governments has also boosted the adoption of dialysis products and services among patients. In addition to this, the improvement in the healthcare sector in emerging nations is likely to strengthen the market for dialysis products and services across the world in the coming years, notes the study.
View exclusive Global strategic Business report :
The report studies the global dialysis products and services market on three fronts: Product type, service type, and its regional spread. On the basis of the type of product, the market has been classified into peritoneal dialysis and hemodialysis. In 2013, the hemodialysis segment led the market with a share of 31%. Experts anticipate this segment to retain its position during the forecast period.
Based on services, the market has been categorized into home dialysis and in-center dialysis. The demand for in-center dialysis services is more than home dialysis services in the global arena. The segment is likely to maintain its dominance in the global market in terms of demand over the forecast period, states the report.
Regionally, the report has segmented the worldwide dialysis products and services market into North America, Asia Pacific, Europe, and the Rest of the World. As per the study, North America led the overall market in 2013 and is anticipated to retain its leadership throughout the forecast period.
Rockwell Medical Technologies Inc., Nipro Corp., NxStage Medical Inc., Nikkiso Co. Ltd., Kawasumi Laboratories Inc., Medical Components Inc., Fresenius SE & Co. KGaA, Covidien Plc, C. R. Bard Inc., DaVita Healthcare Partners Inc., Cantel Medical Corp., Baxter International Inc., B. Braun Melsungen AG, and Asahi Kasei Corp. are some of the key players functioning in the global dialysis products and services market profiled in this research report.